The state of Indiana used a $2 million grant to lure PDS Biotechnology, a Cincinnati-based company developing nanoparticle treatments for the immune system that could prevent cancer, HPV and several other kinds of infections, according to a press release.
Indiana used money from its 21st Century Research and Technology fund.
PDS had operated in the BioStart incubator in Cincinnati, so it has received some services through the state. But PDS had never receive state funding through Third Frontier or other programs, said Matt Schutte of BioOhio. Three months ago, the U.S. National Cancer Institute’s Nanotechnology Characterization Lab announced it would work with PDS to complete preclinical development of its HPV-cancer therapy.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=31292086-648a-4337-b773-8bb24b596051)
Radiology group Radisphere pulls in $10M in equity
Is the early stage funding valley of death a myth?
DePuy Orthopaedics rolls out new hip, shoulder, knee surgery technologies
CWRU researchers: Drug shows promise in reducing Alzheimer’s plaque in brain
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Amy SiegelHow low can you go? Creating value with cheap medical devices
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Jim TateEscape Hatch for Electronic Submission of CQMs for Meaningful Use
Lisa Suennen2012 JP Morgan Healthcare’s (wo)men’s club is changing in a good way
Joe HageA huge American opportunity waiting to happen
Doug MowenMed tech consolidation brings a need for focus. Here are 2 ways to get it
Comments
Post a comment
Ouch, everyone of these hurt. It wouldn’t be so bad if it was just crossing the state line, but they’re moving to Indianapolis. Companies will always be moving, but this isn’t good to see, particularly since BioStart incubated the company.
Comment by Chris Thompson — January 19, 2009 @ 3:51 pm
[...] this year, nanoparticle company PDS Biotechnology left Cincinnati due in part by $2 million from that state’s 21st Century Research and Technology [...]
Comment by 3 million Buckeye bucks later, an original Hoosier biotech returns home : MedCity News — May 7, 2009 @ 10:55 pm
Post a Comment